Beijing, China

Luhua Lai

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Innovations in Cancer Treatment: The Contributions of Luhua Lai

Introduction

Luhua Lai, an accomplished inventor based in Beijing, China, has made significant strides in the field of cancer treatment through his innovative research. With a focus on biochemical solutions, he has developed a groundbreaking patent that offers new avenues for combating tumor diseases.

Latest Patents

Luhua Lai holds a patent for a D-3-phosphoglycerate dehydrogenase allosteric inhibitor and its applications. This invention discloses two classes of allosteric inhibitors targeting specific sites on the enzyme: one is based on a benzoyl hydrazine compound for the allosteric site MDL-1, while the other utilizes a furan compound for the allosteric site MDL-2. In vitro tests and mouse xenograft model experiments have demonstrated that these inhibitors can effectively reduce the enzyme's activity, thereby delaying the growth of cancer cells. This innovative approach has potential applications in treating, preventing, or inhibiting various forms of cancer, including breast cancer, colon cancer, melanoma, and non-small cell lung cancer. Notably, these inhibitors can be used alone, in combination with each other, or alongside other anti-cancer drugs.

Career Highlights

Currently, Luhua Lai is associated with Peking University, where he continues to push the boundaries of cancer research. His dedication to scientific advancement has led to impactful discoveries aimed at improving patient outcomes in oncology.

Collaborations

Throughout his career, Luhua Lai has collaborated with talented individuals such as Ying Liu and Qian Wang. These partnerships have fostered a dynamic research environment, enhancing the potential for innovative solutions in the fight against cancer.

Conclusion

Luhua Lai's contributions to the field of cancer treatment through his patented work on D-3-phosphoglycerate dehydrogenase allosteric inhibitors highlight the importance of innovative thinking in medical research. With continuous collaboration and a focus on groundbreaking discoveries, his work holds promise for improving and extending lives affected by various forms of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…